Company profile

Mabwell Bioscience

688062 · SSE STAR Market

Public Market Listing

688062SSE STAR Market

SSE STAR Market primary exchange listing

Live quotes, historical charts, and market capitalization for Mabwell Bioscience are available on Yahoo Finance.

View quote & market cap on Yahoo Finance ↗

External market data link · No third-party exchange redistribution

Assets

(1 total)
1Total Assets
0Approved
0Phase 3 / Filed
1Phase 1–2 / Early
2Diseases
Quick filter:
Showing 1 of 1 assets
Target & Modality
9MW1911
Phase 2
IL-33/ST2 · ST2 (IL1RL1)Monoclonal antibody
Atopic DermatitisChronic Obstructive Pulmonary Disease

Upcoming events

Research

Unlock the company readout calendar

Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.

Financial reports

Research

Unlock sourced financial history

Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.

Educational data tool. Figures are sourced from company filings and press releases: see each row's filing link. Share price is delayed (~15min) and refreshed periodically, not a real-time feed.